Gorelik Y - Search Results

1

Association of Antibiotic Use with Durability of Biologic Agents in Inflammatory Bowel Disease: a Report from the epi-IIRN.

Gorelik Y, Ghersin I, Shlon D, Friss C, Lujan R, Loewenberg Weisband Y, Greenfeld S, Kariv R, Ledderman N, Matz E, Dotan I, Bar-Yoseph H, Chowers Y, Turner D. Gorelik Y, et al. J Crohns Colitis. 2023 Oct 20;17(9):1410-1417. doi: 10.1093/ecco-jcc/jjad070. J Crohns Colitis. 2023. PMID: 37084088

2

Antibiotic use differentially affects the risk of anti-drug antibody formation during anti-TNFα therapy in inflammatory bowel disease patients: a report from the epi-IIRN.

Gorelik Y, Freilich S, Gerassy-Vainberg S, Pressman S, Friss C, Blatt A, Focht G, Weisband YL, Greenfeld S, Kariv R, Lederman N, Dotan I, Geva-Zatorsky N, Shen-Orr SS, Kashi Y, Chowers Y; IIRN. Gorelik Y, et al. Gut. 2022 Feb;71(2):287-295. doi: 10.1136/gutjnl-2021-325185. Epub 2021 Aug 3. Gut. 2022. PMID: 34344783 Free PMC article.

3

Volume of fluid consumption during preparation for colonoscopy is possibly the single most important determinant of bowel preparation adequacy.

Gorelik Y, Hag E, Hananya T, Leiba R, Chowers Y, Half EE. Gorelik Y, et al. Ann Gastroenterol. 2021 Sep-Oct;34(5):705-712. doi: 10.20524/aog.2021.0642. Epub 2021 Jun 14. Ann Gastroenterol. 2021. PMID: 34475742 Free PMC article.

4

Durability of the First Biologic in Patients with Crohn's Disease: A Nationwide Study from the epi-IIRN.

Atia O, Friss C, Focht G, Magen Rimon R, Ledderman N, Greenfeld S, Ben-Tov A, Loewenberg Weisband Y, Matz E, Gorelik Y, Chowers Y, Dotan I, Turner D. Atia O, et al. Among authors: gorelik y. J Crohns Colitis. 2024 Jan 27;18(1):38-46. doi: 10.1093/ecco-jcc/jjad121. J Crohns Colitis. 2024. PMID: 37465992

5

A personalized network framework reveals predictive axis of anti-TNF response across diseases.

Gerassy-Vainberg S, Starosvetsky E, Gaujoux R, Blatt A, Maimon N, Gorelik Y, Pressman S, Alpert A, Bar-Yoseph H, Dubovik T, Perets B, Katz A, Milman N, Segev M, Chowers Y, Shen-Orr SS. Gerassy-Vainberg S, et al. Among authors: gorelik y. Cell Rep Med. 2024 Jan 16;5(1):101300. doi: 10.1016/j.xcrm.2023.101300. Epub 2023 Dec 19. Cell Rep Med. 2024. PMID: 38118442 Free PMC article.

6

Durability of Adalimumab and Infliximab in Children With Crohn's Disease: A Nationwide Comparison From the epi-IIRN Cohort.

Atia O, Friss C, Focht G, Magen Rimon R, Ledderman N, Ben-Tov A, Loewenberg Weisband Y, Matz E, Gorelik Y, Chowers Y, Dotan I, Turner D. Atia O, et al. Among authors: gorelik y. Inflamm Bowel Dis. 2024 Jan 8:izad301. doi: 10.1093/ibd/izad301. Online ahead of print. Inflamm Bowel Dis. 2024. PMID: 38190498

7

Comparative evaluation of a language model and human specialists in the application of European guidelines for the management of inflammatory bowel diseases and malignancies.

Ghersin I, Weisshof R, Koifman E, Bar-Yoseph H, Ben Hur D, Maza I, Hasnis E, Nasser R, Ovadia B, Dror Zur D, Waterman M, Gorelik Y. Ghersin I, et al. Among authors: gorelik y. Endoscopy. 2024 Apr 18. doi: 10.1055/a-2289-5732. Online ahead of print. Endoscopy. 2024. PMID: 38499197

8

Durability of the First Biologic in Children and Adults With Ulcerative Colitis: A Nationwide Study from the epi-IIRN.

Atia O, Friss C, Focht G, Magen Rimon R, Ledderman N, Greenfeld S, Ben-Tov A, Loewenberg Weisband Y, Matz E, Gorelik Y, Chowers Y, Dotan I, Turner D. Atia O, et al. Among authors: gorelik y. Inflamm Bowel Dis. 2024 Apr 5:izae067. doi: 10.1093/ibd/izae067. Online ahead of print. Inflamm Bowel Dis. 2024. PMID: 38578929

9

Identification of Gene Expression Profiles Associated with an Increased Risk of Post-Operative Recurrence in Crohn's Disease.

Ngollo M, Perez K, Hammoudi N, Gorelik Y, Delord M, Auzolle C, Bottois H, Cazals-Hatem D, Bezault M, Nancey S, Nachury M, Treton X, Fumery M, Buisson A, Barnich N, Seksik P; REMIND Study Group Investigators; Shen-Orr SS, Le Bourhis L, Allez M. Ngollo M, et al. Among authors: gorelik y. J Crohns Colitis. 2022 Aug 30;16(8):1269-1280. doi: 10.1093/ecco-jcc/jjac021. J Crohns Colitis. 2022. PMID: 35143619

10

Hyperglycemia on Admission Predicts Acute Kidney Failure and Renal Functional Recovery among Inpatients.

Gorelik Y, Bloch-Isenberg N, Hashoul S, Heyman SN, Khamaisi M. Gorelik Y, et al. J Clin Med. 2021 Dec 23;11(1):54. doi: 10.3390/jcm11010054. J Clin Med. 2021. PMID: 35011805 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

48 results

Search Page